Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 27

1.

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary.

Institute of Medicine (US).

Washington (DC): National Academies Press (US); 2012.

2.

Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary.

Institute of Medicine (US).

Washington (DC): National Academies Press (US); 2012.

3.

Science funding: Provocative questions in cancer research.

Varmus H, Harlow E.

Nature. 2012 Jan 25;481(7382):436-7. doi: 10.1038/481436a. No abstract available.

PMID:
22281578
4.

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.

Platt R, Carnahan RM, Brown JS, Chrischilles E, Curtis LH, Hennessy S, Nelson JC, Racoosin JA, Robb M, Schneeweiss S, Toh S, Weiner MG.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:1-8. doi: 10.1002/pds.2343.

PMID:
22262586
5.

Assessing research participants' perceptions of their clinical research experiences.

Kost RG, Lee LM, Yessis J, Coller BS, Henderson DK; Research Participant Perception Survey Focus Group Subcommittee.

Clin Transl Sci. 2011 Dec;4(6):403-13. doi: 10.1111/j.1752-8062.2011.00349.x. Epub 2011 Nov 7.

6.

Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.

Law MR, Kawasumi Y, Morgan SG.

Health Aff (Millwood). 2011 Dec;30(12):2338-45. doi: 10.1377/hlthaff.2011.0172.

PMID:
22147862
7.

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS; VX08-770-102 Study Group.

N Engl J Med. 2011 Nov 3;365(18):1663-72. doi: 10.1056/NEJMoa1105185.

8.

Learning What Works: Infrastructure Required for Comparative Effectiveness Research: Workshop Summary.

Institute of Medicine (US) Roundtable on Value & Science-Driven Health Care.

Washington (DC): National Academies Press (US); 2011.

9.

Rethinking health care labor.

Kocher R, Sahni NR.

N Engl J Med. 2011 Oct 13;365(15):1370-2. doi: 10.1056/NEJMp1109649. No abstract available.

10.

Engineering a Learning Healthcare System: A Look at the Future: Workshop Summary.

Institute of Medicine (US) and National Academy of Engineering (US) Roundtable on Value & Science-Driven Health Care.

Washington (DC): National Academies Press (US); 2011.

11.

Impact of National Clinical Guideline recommendations for revascularization of persistently occluded infarct-related arteries on clinical practice in the United States.

Deyell MW, Buller CE, Miller LH, Wang TY, Dai D, Lamas GA, Srinivas VS, Hochman JS.

Arch Intern Med. 2011 Oct 10;171(18):1636-43. doi: 10.1001/archinternmed.2011.315. Epub 2011 Jul 11.

12.

Effect of nesiritide in patients with acute decompensated heart failure.

O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.

N Engl J Med. 2011 Jul 7;365(1):32-43. doi: 10.1056/NEJMoa1100171. Erratum in: N Engl J Med. 2011 Aug 25;365(8):773. Wilson, W H [corrected to Tang, W H W].

13.

The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary.

Institute of Medicine (US) Roundtable on Evidence-Based Medicine; Yong PL, Saunders RS, Olsen LA, editors.

Washington (DC): National Academies Press (US); 2010.

14.

The community oncologist: part of the solution.

Kolodziej MA.

J Natl Compr Canc Netw. 2011 Apr;9(4):345-7. No abstract available.

PMID:
21464143
15.

Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines.

Lee DH, Vielemeyer O.

Arch Intern Med. 2011 Jan 10;171(1):18-22. doi: 10.1001/archinternmed.2010.482.

PMID:
21220656
16.

Oregon's test of value-based insurance design in coverage for state workers.

Kapowich JM.

Health Aff (Millwood). 2010 Nov;29(11):2028-32. doi: 10.1377/hlthaff.2010.0809.

PMID:
21041744
17.

Cluster randomized trials in comparative effectiveness research: randomizing hospitals to test methods for prevention of healthcare-associated infections.

Platt R, Takvorian SU, Septimus E, Hickok J, Moody J, Perlin J, Jernigan JA, Kleinman K, Huang SS.

Med Care. 2010 Jun;48(6 Suppl):S52-7. doi: 10.1097/MLR.0b013e3181dbebcf.

PMID:
20473200
18.

Promoting public awareness of randomised clinical trials using the media: the 'Get Randomised' campaign.

Mackenzie IS, Wei L, Rutherford D, Findlay EA, Saywood W, Campbell MK, Macdonald TM.

Br J Clin Pharmacol. 2010 Feb;69(2):128-35. doi: 10.1111/j.1365-2125.2009.03561.x.

19.

The role of academic health science systems in the transformation of medicine.

Dzau VJ, Ackerly DC, Sutton-Wallace P, Merson MH, Williams RS, Krishnan KR, Taber RC, Califf RM.

Lancet. 2010 Mar 13;375(9718):949-53. doi: 10.1016/S0140-6736(09)61082-5. Epub 2009 Sep 30. No abstract available.

PMID:
19800111
20.

Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M.

N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.

Supplemental Content

Support Center